Dansey Roger D
- SEC CIK
- 0001741836
No open-market purchases or sales filed in the past year.
Current role at each company
- INO Inovio Pharmaceuticals, Inc.Directoras of May 21, 2026
- NRIX Nurix Therapeutics, Inc.Directoras of May 15, 2026
- BCYC Bicycle Therapeutics PLCDirectoras of Jan 6, 2026
- KRON Kronos Bio, Inc.Directoras of Jun 20, 2025
- SGEN Seagen Inc.President, R&D & CMOas of Dec 15, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dansey Roger D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SGEN Seagen Inc.
President, R&D & CMO22 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2023 (view filing) | Sep 21 | 1 day | Dansey Roger DPresident, R&D & CMO | SSale | −71 | $206.50 | −$14.7K | −0.1%116.7K after | |
| Sep 1, 2023 (view filing) | Aug 31 | 1 day | Dansey Roger DPresident, R&D & CMO | SSale | −4.03K | $206.97 | −$833.9K | −3.5%111.8K after | |
| Aug 30, 2023 (view filing) | Aug 29 | 1 day | Dansey Roger DPresident, R&D & CMO | SSale | −1.02K | $206.00 | −$209.3K | −0.9%115.8K after | |
| Apr 19, 2023 (view filing) | Apr 17 | 2 days | Dansey Roger DPresident, R&D & CMO | SSale | −10.0K | $205.95 | −$2.06M | −9.1%99.4K after | 10b5-1 |
| Apr 7, 2023 (view filing) | Apr 6 | 1 day | Dansey Roger DPresident, R&D & CMO | SSale | −333 | $205.86 | −$68.6K | −0.3%99.4K after | From original10b5-1 |
| Mar 17, 2023 (view filing) | Mar 15 | 2 days | Dansey Roger DPresident, R&D & CMO | SSale | −10.0K | $199.81 | −$2.00M | −9.4%96.9K after | |
| Feb 17, 2023 (view filing) | Feb 15 | 2 days | Dansey Roger DPresident, R&D & CMO | SSale | −10.0K | $140.64 | −$1.41M | −9.4%96.9K after | 3 lots |
| Feb 3, 2023 (view filing) | Feb 2 | 1 day | Dansey Roger DPresident, R&D & CMO | SSale | −783 | $138.52 | −$108.5K | −0.8%96.9K after | |
| Jan 26, 2023 (view filing) | Jan 24 | 2 days | Dansey Roger DPresident, R&D & CMO | SSale | −10.0K | $135.00 | −$1.35M | −9.3%97.5K after | |
| Jan 6, 2023 (view filing) | Jan 4-5 | 2 days | Dansey Roger DPresident R&D & CMO | SSale | −10.0K | $135.00 | −$1.35M | −9.3%97.5K after | 2 lots |